Helene B. Schlecht

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Clinical Utility of Whole-Genome Sequencing to Aid Histologic Diagnosis and to Direct Personalized Medicine in Salivary Gland Cancer.

Clinical Utility of Whole-Genome Sequencing to Aid Histologic Diagnosis and to Direct Personalized Medicine in Salivary Gland Cancer.

Journal: JCO precision oncology

Published: October 30, 2025

Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma.

Homologous recombination deficiency in unselected cases of high-grade ovarian carcinoma.

Journal: Journal of medical genetics

Published: May 05, 2025

Whole Genome Sequencing to Identify Novel Germline Fumarate Hydratase Mutation in Child With Bilateral Renal Cell Carcinoma.

Whole Genome Sequencing to Identify Novel Germline Fumarate Hydratase Mutation in Child With Bilateral Renal Cell Carcinoma.

Journal: Clinical genetics

Published: December 23, 2024

The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023-2024).

The NHS England Jewish BRCA Testing Programme: overview after first year of implementation (2023-2024).

Journal: Journal of medical genetics

Published: September 18, 2024

UK-based clinical testing programme for somatic and germline BRCA1/2, ATM and CDK12 mutations in prostate cancer: first results.

UK-based clinical testing programme for somatic and germline BRCA1/2, ATM and CDK12 mutations in prostate cancer: first results.

Journal: BMJ oncology

Published: September 04, 2024

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer.

Journal: British journal of cancer

Published: May 26, 2024

Clinicopathological Analysis of a European Cohort of MYOD1 Mutant Rhabdomyosarcomas in Children and Young Adults.

Clinicopathological Analysis of a European Cohort of MYOD1 Mutant Rhabdomyosarcomas in Children and Young Adults.

Journal: Pediatric blood & cancer

Published: May 08, 2024

Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene.

Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: April 13, 2024

Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer.

Real-World Concordance between Germline and Tumour BRCA1/2 Status in Epithelial Ovarian Cancer.

Journal: Cancers

Published: November 24, 2023

Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.

Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.

Journal: Familial cancer

Published: October 18, 2023

Germline testing of BRCA1, BRCA2, PALB2 and CHEK2 c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM, RAD51C and RAD51D in over 400.

Germline testing of BRCA1, BRCA2, PALB2 and CHEK2 c.1100delC in 1514 triple negative familial and isolated breast cancers from a single centre, with extended testing of ATM, RAD51C and RAD51D in over 400.

Journal: Journal of medical genetics

Published: October 03, 2023

Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.

Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 18, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026